Skin of ColorSOCU Poster Abstracts

Twenty Nail Dystrophy; a case report from Disharc, Nepal

By June 12, 2020July 1st, 2020No Comments

Skin of Color Update

Featured Poster Abstract

The following is a selected scientific poster abstract from the 2019 Skin of Color Update.

Learn More

"Twenty Nail Dystrophy; a case report from Disharc, Nepal"

Author: Prarthana Adhikari, MD

The following is a selected scientific poster abstract from the 2019 Skin of Color Update.

Twenty-nail dystrophy (TND) is rare and less reported chronic inflammatory disorder affecting nail matrix of all twenty nails. Literature reports mainly as idiopathic but are also associated with cutaneous or systemic disorders among childhood. It clinically presents as rough, thin, brittle lustureless nails with multiple pits. The diagnosis was made clinically but pathological study shows spongiosis and exocytosis of inflammatory cells in epithelium.

Case Report: We present a case of 9-year-old boy with complaints of rough, thin and pitted nails. He was asymptomatic but was under antithyroid medication for hypothyroidism. His only concern was bad appearance. He was given mild topical steroids and emollients. After 6 months of follow-up, patient has shown sign of improvement. Therefore, TND can also be inferenced as self-limiting disease with minimum treatment can have positive reference.

Skin of Color Scientific Poster Abstracts

View a curated selection of scientific poster abstracts from the Skin of Color Update conference below.

Explore More

Skin of Color Update Virtual

The Experts’ Forum for Multicultural Dermatology

The US population is growing and evolving and the clinical profile of the average patient presenting to the dermatologist is changing. One in three Americans self-identify as member of a non-caucasian racial or ethnic group. Data shows as of 2020, individuals of non-Caucasian, multi-racial descent will comprise more than 50% of the population.

Skin of Color Update Virtual 2020 Topics

 

  • Hair Loss
  • Acne
  • Rosacea
  • Skin Care with Cosmeceuticals
  • PRP
  • Psoriasis
  • Scalp Psoriasis
  • Skin Cancer
  • and more!
Register for SOCU 2020 Now

You May Also Like

Impact of Low-Dose Oral Minocycline (DFD-29) on Skin, Gastrointestinal, and Vaginal Microflora in Healthy Adults

| Featured Articles, Latest News, Rosacea, Women | No Comments
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…
Journal of Drugs in Dermatology JDD Article about The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

| Featured Articles, Latest News, Skin Cancer | No Comments
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Journal of Drugs in Dermatology JDD Article about GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities

| Featured Articles, Hidradenitis Suppurativa, Latest News | No Comments
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…

Leave a Reply